Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Acq. announced
Appointed director
CC transcript
Inv. presentation

VIROPHARMA INC (VPHM) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/28/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
01/28/2014 4 CLAYPOOL WILLIAM D MD (Director) has filed a Form 4 on VIROPHARMA INC
01/28/2014 4 McHugh Julie (Director) has filed a Form 4 on VIROPHARMA INC
Txns: Unknown transaction of 8,666 shares @ $50, valued at $433.3k
Disposed/sold 15,000 options to buy @ $31.74, valued at $476.1k
Disposed/sold 15,000 options to buy @ $25.25, valued at $378.8k
Disposed/sold 4,500 restricted stock units @ $0
Disposed/sold 2,084 restricted stock units @ $0
Disposed/sold 12,500 options to buy @ $27.99, valued at $349.9k
01/28/2014 4 Leone John R (Director) has filed a Form 4 on VIROPHARMA INC
01/28/2014 4 GLASER ROBERT (Director) has filed a Form 4 on VIROPHARMA INC
01/28/2014 4 DOUGHERTY MICHAEL R (Director) has filed a Form 4 on VIROPHARMA INC
01/28/2014 4 BROOKE PAUL A (Director) has filed a Form 4 on VIROPHARMA INC
Txns: Unknown transaction of 128,314 shares @ $50, valued at $6.4M
Disposed/sold 15,000 options to buy @ $10.76, valued at $161.4k
Disposed/sold 25,000 options to buy @ $3, valued at $75k
Disposed/sold 10,000 options to buy @ $9.15, valued at $91.5k
Disposed/sold 10,000 options to buy @ $20.15, valued at $201.5k
Disposed/sold 10,000 options to buy @ $17.76, valued at $177.6k
Disposed/sold 15,000 options to buy @ $25.25, valued at $378.8k
Disposed/sold 15,000 options to buy @ $31.74, valued at $476.1k
Disposed/sold 15,000 options to buy @ $17.3, valued at $259.5k
Disposed/sold 15,000 options to buy @ $5.68, valued at $85.2k
Disposed/sold 4,500 restricted stock units @ $0
01/28/2014 4 Wolf John Peter III (VP, General Counsel) has filed a Form 4 on VIROPHARMA INC
01/28/2014 4 SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC
01/28/2014 4 Rowland Charles A Jr (VP, CFO) has filed a Form 4 on VIROPHARMA INC
Txns: Unknown transaction of 87,026 shares @ $50, valued at $4.4M
Granted 48,878 shares @ $0
Disposed/sold 48,878 shares @ $0
Disposed/sold 52,593 options to buy @ $13.5, valued at $710k
Disposed/sold 13,714 options to buy @ $8.86, valued at $121.5k
Disposed/sold 50,000 options to buy @ $11.31, valued at $565.5k
Disposed/sold 40,261 options to buy @ $17.84, valued at $718.3k
Disposed/sold 40,261 options to buy @ $17.98, valued at $723.9k
Disposed/sold 27,265 options to buy @ $28.16, valued at $767.8k
Disposed/sold 35,723 options to buy @ $20.07, valued at $717k
Disposed/sold 34,570 options to buy @ $23.37, valued at $807.9k
01/28/2014 4 Pietrusko Robert (VP, Regulatory & Quality) has filed a Form 4 on VIROPHARMA INC
01/28/2014 4 MILANO VINCENT (President and CEO) has filed a Form 4 on VIROPHARMA INC
Txns: Unknown transaction of 482,281 shares @ $50, valued at $24.1M
Granted 311,798 shares @ $0
Disposed/sold 311,798 shares @ $0
Disposed/sold 54,932 options to buy @ $19.73, valued at $1.1M
Disposed/sold 33,714 options to buy @ $8.86, valued at $298.7k
Disposed/sold 17,500 options to buy @ $11.31, valued at $197.9k
Disposed/sold 80,521 options to buy @ $17.84, valued at $1.4M
Disposed/sold 80,521 options to buy @ $17.98, valued at $1.4M
Disposed/sold 54,530 options to buy @ $28.16, valued at $1.5M
Disposed/sold 71,447 options to buy @ $20.07, valued at $1.4M
Disposed/sold 65,299 options to buy @ $23.37, valued at $1.5M
01/28/2014 4 Kirby John J. (V.P., Chief Accounting Officer) has filed a Form 4 on VIROPHARMA INC
01/28/2014 4 Fletcher Robert C. (V.P., Business Development) has filed a Form 4 on VIROPHARMA INC
01/28/2014 4 DOYLE THOMAS F (VP Strategic Initiatives) has filed a Form 4 on VIROPHARMA INC
01/28/2014 4 Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC
01/22/2014 4 DOYLE THOMAS F (VP Strategic Initiatives) has filed a Form 4 on VIROPHARMA INC
01/21/2014 4 Wolf John Peter III (VP, General Counsel) has filed a Form 4 on VIROPHARMA INC
01/21/2014 4 MILANO VINCENT (President and CEO) has filed a Form 4 on VIROPHARMA INC
Txns: Exercised 18,582 options to buy @ $3.14, valued at $58.3k
Exercised 7,503 options to buy @ $7.05, valued at $52.9k
Exercised 5,068 options to buy @ $19.73, valued at $100k
Exercised 6,561 options to buy @ $15.24, valued at $100k
Exercised 6,251 options to buy @ $9.96, valued at $62.3k
Exercised 3,778 options to buy @ $9.99, valued at $37.7k
Exercised 7,407 options to buy @ $13.5, valued at $100k
Exercised 12,690 options to buy @ $5.91, valued at $75k
Exercised 11,286 options to buy @ $8.86, valued at $100k
01/10/2014 4 SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC
01/10/2014 4 Rowland Charles A Jr (VP, CFO) has filed a Form 4 on VIROPHARMA INC
Txns: Paid exercise price by delivering 847 shares @ $49.8, valued at $42.2k
Paid exercise price by delivering 2,773 shares @ $49.8, valued at $138.1k
Paid exercise price by delivering 2,271 shares @ $49.8, valued at $113.1k
Paid exercise price by delivering 558 shares @ $49.8, valued at $27.8k
Exercised 5,460 options to buy @ $5.91, valued at $32.3k
Exercised 13,080 options to buy @ $8.86, valued at $115.9k
Exercised 8,361 options to buy @ $11.96, valued at $100k
Exercised 1,852 options to buy @ $13.5, valued at $25k
01/10/2014 4 Pietrusko Robert (VP, Regulatory & Quality) has filed a Form 4 on VIROPHARMA INC
01/10/2014 4 Broom Colin MD (VP & Chief Scientific Officer) has filed a Form 4 on VIROPHARMA INC
01/08/2014 4 BROOKE PAUL A (Director) has filed a Form 4 on VIROPHARMA INC
Txns: Paid exercise price by delivering 686 shares @ $49.89, valued at $34.2k
Exercised 10,000 options to buy @ $3.42, valued at $34.2k
01/07/2014 4 MILANO VINCENT (President and CEO) has filed a Form 4 on VIROPHARMA INC
Txns: Exercised 40,309 options to buy @ $3.55, valued at $143.1k
01/03/2014 4 McHugh Julie (Director) has filed a Form 4 on VIROPHARMA INC
Txns: Granted 2,083 shares @ $0
12/31/2013 4 Pietrusko Robert (VP, Regulatory & Quality) has filed a Form 4 on VIROPHARMA INC
12/31/2013 4 Rowland Charles A Jr (VP, CFO) has filed a Form 4 on VIROPHARMA INC
Txns: Paid exercise price by delivering 704 shares @ $49.86, valued at $35.1k
Exercised 4,540 options to buy @ $5.91, valued at $26.8k
12/31/2013 4 SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC
12/20/2013 4 Pietrusko Robert (VP, Regulatory & Quality) has filed a Form 4 on VIROPHARMA INC
12/20/2013 4 Rowland Charles A Jr (VP, CFO) has filed a Form 4 on VIROPHARMA INC
Txns: Paid exercise price by delivering 9,330 shares @ $49.74, valued at $464.1k
Paid exercise price by delivering 3,964 shares @ $49.74, valued at $197.2k
Paid exercise price by delivering 11,835 shares @ $49.74, valued at $588.7k
Exercised 15,800 options to buy @ $11.96, valued at $189k
Exercised 10,000 options to buy @ $5.91, valued at $59.1k
Exercised 23,206 options to buy @ $8.86, valued at $205.6k
12/20/2013 4 DOUGHERTY MICHAEL R (Director) has filed a Form 4 on VIROPHARMA INC
12/20/2013 4 SOLAND DANIEL B (VP, COO) has filed a Form 4 on VIROPHARMA INC
12/20/2013 4 MILANO VINCENT (President and CEO) has filed a Form 4 on VIROPHARMA INC
Txns: Paid exercise price by delivering 15,655 shares @ $49.74, valued at $778.7k
Paid exercise price by delivering 33,441 shares @ $49.74, valued at $1.7M
Paid exercise price by delivering 30,410 shares @ $49.74, valued at $1.5M
Paid exercise price by delivering 30,706 shares @ $49.74, valued at $1.5M
Paid exercise price by delivering 10,704 shares @ $49.74, valued at $532.4k
Paid exercise price by delivering 63,528 shares @ $49.74, valued at $3.2M
Paid exercise price by delivering 46,649 shares @ $49.74, valued at $2.3M
Paid exercise price by delivering 522 shares @ $49.74, valued at $26k
Paid exercise price by delivering 75,462 shares @ $49.74, valued at $3.8M
Paid exercise price by delivering 30,733 shares @ $49.74, valued at $1.5M
Exercised 32,497 options to buy @ $7.05, valued at $229.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy